Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Infection and Immunity|September 30, 2009
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165cS Olugbile, C Kulangara, G Bang, et al.Journal of Autoimmunity|August 11, 1999
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assayP M Bayer, S Bauerfeind, J Bienvenu, et al.AIDS (London, England)|August 28, 1999
Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort StudyP A Bart, J Y Meuwly, J M Corpataux, et al.Allergy|March 31, 2015
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disordersO Boyman, C Kaegi, M Akdis, et al.Revue Medicale Suisse|April 22, 2015
[Giant cell arteritis: guidelines of the University Hospital of Lausanne]S Tsetsou, P Michel, C Ribi, et al.Revue Medicale Suisse|February 19, 2013
[What is new in 2012 for the specialist in hospital internal medicine?]E Pelet, M Gagliano, A Garnier, et al.Nature|January 5, 2001
Subduction and collision processes in the Central Andes constrained by converted seismic phasesX Yuan, S V Sobolev, R Kind, et al.The Journal of Clinical Investigation|March 23, 2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAG P Rizzardi, R J De Boer, S Hoover, et al.AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.Nature Medicine|July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapyS Fleury, R J de Boer, G P Rizzardi, et al.Pageof 15